Imaging phenotypes of chronic obstructive pulmonary disease

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 6, 2010, Pages 1340-1352

  Ley Zaporozhan, Julia ^a   Van Beek, Edwin J R ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

airways; COPD; CT; emphysema; function; morphology; MRI

Indexed keywords

AIRWAY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EMPHYSEMA; LUNG PARENCHYMA; LUNG PERFUSION; LUNG VENTILATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW;

BRONCHI; CHRONIC DISEASE; EMPHYSEMA; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; PERFUSION; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649665311     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22376     Document Type: Review

References (102)

1. Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006; 27: 397-412.
2. GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Executive summary, updated 2009:. Last accessed: December 15, 2009.
3. Stockley RA, Mannino D, Barnes PJ., Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6: 524-526.
4. Roy K, Smith J, Kolsum U, Borrill Z, Vestbo J, Singh D., COPD phenotype description using principal components analysis. Respir Res 2009; 10: 41.
5. Esteban C, Quintana JM, Egurrola M, et al. Classifying the severity of COPD: are the new severity scales better than the old ? Int J Tuberc Lung Dis 2009; 13: 783-790.
6. Bergin C, Muller N, Nichols DM, et al. The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am Rev Respir Dis 1986; 133: 541-546.
7. Lynch DA., Imaging of small airways disease and chronic obstructive pulmonary disease. Clin Chest Med 2008; 29: 165-179, vii.
8. Kubo T, Lin PJ, Stiller W, et al. Radiation dose reduction in chest CT: a review. AJR Am J Roentgenol 2008; 190: 335-343.
9. Mayer D, Bartz D, Fischer J, et al. Hybrid segmentation and virtual bronchoscopy based on CT images. Acad Radiol 2004; 11: 551-565.
10. Kiraly AP, Odry BL, Godoy MC, Geiger B, Novak CL, Naidich DP., Computer-aided diagnosis of the airways: beyond nodule detection. J Thorac Imaging 2008; 23: 105-113.
11. Boedeker KL, McNitt-Gray MF, Rogers SR, et al. Emphysema: effect of reconstruction algorithm on CT imaging measures. Radiology 2004; 232: 295-301.
12. Ley-Zaporozhan J, Ley S, Weinheimer O, et al. Quantitative analysis of emphysema in 3D using MDCT: influence of different reconstruction algorithms. Eur J Radiol 2008; 65: 228-234.
13. Madani A, De Maertelaer V, Zanen J, Gevenois PA., Pulmonary emphysema: radiation dose and section thickness at multidetector CT quantification- comparison with macroscopic and microscopic morphometry. Radiology 2007; 243: 250-257.
14. Zaporozhan J, Ley S, Weinheimer O, et al. Multi-detector CT of the chest: influence of dose onto quantitative evaluation of severe emphysema: a simulation study. J Comput Assist Tomogr 2006; 30: 460-468.
15. Heussel CP, Kappes J, Hantusch R, et al. Contrast enhanced CT-scans are not comparable to non-enhanced scans in emphysema quantification. Eur J Radiol 2010; 74: 473-478.
16. Berger P, Laurent F, Begueret H, et al. Structure and function of small airways in smokers: relationship between air trapping at CT and airway inflammation. Radiology 2003; 228: 85-94.
17. Verschakelen JA, Scheinbaum K, Bogaert J, Demedts M, Lacquet LL, Baert AL., Expiratory CT in cigarette smokers: correlation between areas of decreased lung attenuation, pulmonary function tests and smoking history. Eur Radiol 1998; 8: 1391-1399.
18. Kauczor HU, Hast J, Heussel CP, Schlegel J, Mildenberger P, Thelen M., Focal airtrapping at expiratory high-resolution CT: comparison with pulmonary function tests. Eur Radiol 2000; 10: 1539-1546.
19. Hansell DM., Small airways diseases: detection and insights with computed tomography. Eur Respir J 2001; 17: 1294-1313.
20. Webb WR., Thin-section CT of the secondary pulmonary lobule: anatomy and the image-the 2004 Fleischner lecture. Radiology 2006; 239: 322-338.
21. Aziz ZA, Wells AU, Desai SR, et al. Functional impairment in emphysema: contribution of airway abnormalities and distribution of parenchymal disease. AJR Am J Roentgenol 2005; 185: 1509-1515.
22. Bankier AA, De Maertelaer V, Keyzer C, Gevenois PA., Pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry. Radiology 1999; 211: 851-858.
23. Park JW, Hong YK, Kim CW, Kim DK, Choe KO, Hong CS., High-resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J Investig Allergol Clin Immunol 1997; 7: 186-192.
24. Goldin JG., Quantitative CT of the lung. Radiol Clin North Am 2002; 40: 145-162.
25. Hogg JC., State of the art. Bronchiolitis in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 489-493.
26. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653.
27. Nakano Y, Muller NL, King GG, et al. Quantitative assessment of airway remodeling using high-resolution CT. Chest 2002; 122 (6 Suppl): 271S-275S.
28. Venkatraman R, Raman R, Raman B, et al. Fully automated system for three-dimensional bronchial morphology analysis using volumetric multidetector computed tomography of the chest. J Digit Imaging 2006; 19: 132-139.
29. Tschirren J, Hoffman EA, McLennan G, Sonka M., Intrathoracic airway trees: segmentation and airway morphology analysis from low-dose CT scans. IEEE Trans Med Imaging 2005; 24: 1529-1539.
30. Hasegawa M, Nasuhara Y, Onodera Y, et al. Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 1309-1315.
31. Heussel CP, Herth FJ, Kappes J, et al. Fully automatic quantitative assessment of emphysema in computed tomography: comparison with pulmonary function testing and normal values. Eur Radiol 2009; 19: 2391-2402.
32. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC., Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152: 653-657.
33. Gevenois PA, De Vuyst P, de Maertelaer V, et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996; 154: 187-192.
34. Baldi S, Miniati M, Bellina CR, et al. Relationship between extent of pulmonary emphysema by high-resolution computed tomography and lung elastic recoil in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 585-589.
35. Stoel BC, Stolk J., Optimization and standardization of lung densitometry in the assessment of pulmonary emphysema. Invest Radiol 2004; 39: 681-688.
36. Madani A, Zanen J, de Maertelaer V, Gevenois PA., Pulmonary emphysema: objective quantification at multi-detector row CT-comparison with macroscopic and microscopic morphometry. Radiology 2006; 238: 1036-1043.
37. Kinsella M, Muller NL, Abboud RT, Morrison NJ, DyBuncio A., Quantitation of emphysema by computed tomography using a "density mask" program and correlation with pulmonary function tests. Chest 1990; 97: 315-321.
38. Arakawa A, Yamashita Y, Nakayama Y, et al. Assessment of lung volumes in pulmonary emphysema using multidetector helical CT: comparison with pulmonary function tests. Comput Med Imaging Graph 2001; 25: 399-404.
39. Zaporozhan J, Ley S, Eberhardt R, et al. Paired inspiratory/expiratory volumetric thin-slice CT scan for emphysema analysis: comparison of different quantitative evaluations and pulmonary function test. Chest 2005; 128: 3212-3220.
40. Bakker ME, Stolk J, Putter H, et al. Variability in densitometric assessment of pulmonary emphysema with computed tomography. Invest Radiol 2005; 40: 777-783.
41. Martinez FJ, Foster G, Curtis JL, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173: 1326-1334.
42. Naunheim KS, Wood DE, Krasna MJ, et al. Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg 2006; 131: 43-53.
43. Washko GR, Martinez FJ, Hoffman EA, et al. Physiologic and computed tomographic predictors of outcome from lung volume reduction surgery. Am J Respir Crit Care Med 2010; 181: 494-500.
44. Nakano Y, Sakai H, Muro S, et al. Comparison of low attenuation areas on computed tomographic scans between inner and outer segments of the lung in patients with chronic obstructive pulmonary disease: incidence and contribution to lung function. Thorax 1999; 54: 384-389.
45. Mishima M, Hirai T, Itoh H, et al. Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 1999; 96: 8829-8834.
46. Hoffman EA, Simon BA, McLennan G., State of the art. A structural and functional assessment of the lung via multidetector-row computed tomography: phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 519-532.
47. Xu Y, Sonka M, McLennan G, Guo J, Hoffman EA., MDCT-based 3-D texture classification of emphysema and early smoking related lung pathologies. IEEE Trans Med Imaging 2006; 25: 464-475.
48. Revel MP, Faivre JB, Remy-Jardin M, et al. Automated lobar quantification of emphysema in patients with severe COPD. Eur Radiol 2008; 18: 2723-2730.
49. Mair G, Miller JJ, McAllister D, et al. Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers. Eur Respir J 2009; 33: 536-542.
50. Owsijewitsch M, Ley-Zaporozhan J, Kuhnigk J-M, Heussel CP, Kauczor H-U, Ley S., Phenotyping of COPD: comparison of an anatomical and a non-anatomical approach in studying the distribution of emphysema between the upper and lower lung. Eur Radiol 2009; 19 (Suppl 1): 237.
51. Owsijewitsch M, Ley-Zaporozhan J, Kuhnigk J-M, Heussel C, Ley S, Kauczor H-U,. Distribution of emphysema between rind and core region of the lung in COPD patients. RSNA (Radiological Society of North America) Chicago: 2008. p SSG04-07.
52. Hoffman EA, Chon D., Computed tomography studies of lung ventilation and perfusion. Proc Am Thorac Soc 2005; 2: 492-498.
53. van Beek EJ, Hoffman EA., Functional imaging: CT and MRI. Clin Chest Med 2008; 29: 195-216, vii.
54. Alford SK, van Beek EJ, Hudson M, Baumhauer H, McLennan G, Hoffman EA., Characterization of regional alterations in pulmonary perfusion via MDCT in nonsmokers and smokers. Eur Radiol 2008; 18 (Suppl 1): 330-331.
55. Fuld MK, Simon BA, van Beek EJ, Morgan JH, Hoffman EA., Establishing "normal": regional ventilation via dynamic xenon-CT in humans. Proc Am Thorac Soc 2009: A3530.
56. Puderbach M, Hintze C, Ley S, Eichinger M, Kauczor HU, Biederer J., MR imaging of the chest: a practical approach at 1.5T. Eur J Radiol 2007; 64: 345-355.
57. Ley-Zaporozhan J, Ley S, Kauczor HU., Proton MRI in COPD. COPD 2007; 4: 55-65.
58. Bankier AA, O'Donnell CR, Mai VM, et al. Impact of lung volume on MR signal intensity changes of the lung parenchyma. J Magn Reson Imaging 2004; 20: 961-966.
59. Hatabu H, Gaa J, Tadamura E, et al. MR imaging of pulmonary parenchyma with a half-Fourier single-shot turbo spin-echo (HASTE) sequence. Eur J Radiol 1999; 29: 152-159.
60. Biederer J, Both M, Graessner J, et al. Lung morphology: fast MR imaging assessment with a volumetric interpolated breath-hold technique: initial experience with patients. Radiology 2003; 226: 242-249.
61. Ley-Zaporozhan J, Puderbach M, Kauczor HU., MR for the evaluation of obstructive pulmonary disease. Magn Reson Imaging Clin N Am 2008; 16: 291-308.
62. Hatabu H, Gaa J, Kim D, Li W, Prasad PV, Edelman RR., Pulmonary perfusion: qualitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and inversion recovery turbo FLASH. Magn Reson Med 1996; 36: 503-508.
63. Hatabu H, Tadamura E, Levin DL, et al. Quantitative assessment of pulmonary perfusion with dynamic contrast-enhanced MRI. Magn Reson Med 1999; 42: 1033-1038.
64. Fink C, Puderbach M, Bock M, et al. Regional lung perfusion: assessment with partially parallel three-dimensional MR imaging. Radiology 2004; 231: 175-184.
65. Fink C, Ley S, Kroeker R, Requardt M, Kauczor HU, Bock M., Time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the chest: combination of parallel imaging with view sharing (TREAT). Invest Radiol 2005; 40: 40-48.
66. Ley-Zaporozhan J, Ley S, Eberhardt R, et al. Assessment of the relationship between lung parenchymal destruction and impaired pulmonary perfusion on a lobar level in patients with emphysema. Eur J Radiol 2007; 63: 76-83.
67. van Beek EJ, Wild JM, Kauczor HU, Schreiber W, Mugler JP 3rd, de Lange EE,. Functional MRI of the lung using hyperpolarized 3-helium gas. J Magn Reson Imaging 2004; 20: 540-554.
68. Mathew L, Kirby M, Etemad-Rezai R, Wheatley A, McCormack DG, Parraga G., Hyperpolarized (3)He magnetic resonance imaging: preliminary evaluation of phenotyping potential in chronic obstructive pulmonary disease. Eur J Radiol 2009 [Epub ahead of print].
69. Hersman FW, Ruset IC, Ketel S, et al. Large production system for hyperpolarized 129Xe for human lung imaging studies. Acad Radiol 2008; 15: 683-692.
70. Patz S, Muradian I, Hrovat MI, et al. Human pulmonary imaging and spectroscopy with hyperpolarized 129Xe at 0.2T. Acad Radiol 2008; 15: 713-727.
71. Iwasawa T, Takahashi H, Ogura T, et al. Correlation of lung parenchymal MR signal intensity with pulmonary function tests and quantitative computed tomography (CT) evaluation: a pilot study. J Magn Reson Imaging 2007; 26: 1530-1536.
72. Ley-Zaporozhan J, Ley S, Eberhardt R, Kauczor HU, Heussel CP., Visualization of morphological parenchymal changes in emphysema: comparison of different MRI sequences to 3D-HRCT. Eur J Radiol 2010; 73: 43-49.
73. Euler US, Liljestrand G., Observation on the pulmonary arterial blood pressuer in the cat. Acta Physiol Scand 1946; 12: 301-320.
74. Cederlund K, Hogberg S, Jorfeldt L, et al. Lung perfusion scintigraphy prior to lung volume reduction surgery. Acta Radiol 2003; 44: 246-251.
75. Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127: 1531-1536.
76. Amundsen T, Torheim G, Kvistad KA, et al. Perfusion abnormalities in pulmonary embolism studied with perfusion MRI and ventilation-perfusion scintigraphy: an intra-modality and inter-modality agreement study. J Magn Reson Imaging 2002; 15: 386-394.
77. Morino S, Toba T, Araki M, et al. Noninvasive assessment of pulmonary emphysema using dynamic contrast-enhanced magnetic resonance imaging. Exp Lung Res 2006; 32: 55-67.
78. Ohno Y, Hatabu H, Murase K, et al. Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: preliminary experience in 40 subjects. J Magn Reson Imaging 2004; 20: 353-365.
79. Jang YM, Oh YM, Seo JB, et al. Quantitatively assessed dynamic contrast-enhanced magnetic resonance imaging in patients with chronic obstructive pulmonary disease: correlation of perfusion parameters with pulmonary function test and quantitative computed tomography. Invest Radiol 2008; 43: 403-410.
80. Ohno Y, Sugimura K, Hatabu H., Clinical oxygen-enhanced magnetic resonance imaging of the lung. Top Magn Reson Imaging 2003; 14: 237-243.
81. Muller CJ, Schwaiblmair M, Scheidler J, et al. Pulmonary diffusing capacity: assessment with oxygen-enhanced lung MR imaging preliminary findings. Radiology 2002; 222: 499-506.
82. Stadler A, Stiebellehner L, Jakob PM, Arnold JF, Bankier AA., [T1 maps and O(2)-enhanced MRT of the diseased lung emphysema, fibrosis, mucoviscidosis.] Radiologe 2006; 46: 282: 284-289.
83. Stadler A, Jakob PM, Griswold M, Stiebellehner L, Barth M, Bankier AA., T(1) mapping of the entire lung parenchyma: influence of respiratory phase and correlation to lung function test results in patients with diffuse lung disease. Magn Reson Med 2008; 59: 96-101.
84. Ley S, Puderbach M, Risse F, et al. Impact of oxygen inhalation on the pulmonary circulation: assessment by magnetic resonance (MR)-perfusion and MR-flow measurements. Invest Radiol 2007; 42: 283-290.
85. Kauczor HU, Hofmann D, Kreitner KF, et al. Normal and abnormal pulmonary ventilation: visualization at hyperpolarized He-3 MR imaging. Radiology 1996; 201: 564-568.
86. Guenther D, Eberle B, Hast J, et al. (3)He MRI in healthy volunteers: preliminary correlation with smoking history and lung volumes. NMR Biomed 2000; 13: 182-189.
87. Zaporozhan J, Ley S, Gast KK, et al. Functional analysis in single-lung transplant recipients: a comparative study of high-resolution CT, (3)He-MRI, and pulmonary function tests. Chest 2004; 125: 173-181.
88. Gast KK, Viallon M, Eberle B, et al. MRI in lung transplant recipients using hyperpolarized (3)He: comparison with CT. J Magn Reson Imaging 2002; 15: 268-274.
89. van Beek EJ, Dahmen AM, Stavngaard T, et al. Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial. Eur Respir J 2009; 34: 1311-1321.
90. Ray N, Acton ST, Altes T, de Lange EE, Brookeman JR., Merging parametric active contours within homogeneous image regions for MRI-based lung segmentation. IEEE Trans Med Imaging 2003; 22: 189-199.
91. Woodhouse N, Wild JM, Paley MN, et al. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to never-smokers. J Magn Reson Imaging 2005; 21: 365-369.
92. Lehmann F, Knitz F, Weiler N, et al. A software tool for analysis and quantification of regional pulmonary ventilation using dynamic hyperpolarised-(3)He-MRI. Fortschr Röntgenstr 2004; 176: 1399-1408.
93. Salerno M, Altes TA, Brookeman JR, de Lange EE, Mugler JP 3rd,. Dynamic spiral MRI of pulmonary gas flow using hyperpolarized (3)He: preliminary studies in healthy and diseased lungs. Magn Reson Med 2001; 46: 667-677.
94. Wild JM, Paley MN, Kasuboski L, et al. Dynamic radial projection MRI of inhaled hyperpolarized 3He gas. Magn Reson Med 2003; 49: 991-997.
95. Gierada DS, Saam B, Yablonskiy D, Cooper JD, Lefrak SS, Conradi MS., Dynamic echo planar MR imaging of lung ventilation with hyperpolarized (3)He in normal subjects and patients with severe emphysema. NMR Biomed 2000; 13: 176-181.
96. Gast KK, Puderbach MU, Rodriguez I, et al. Distribution of ventilation in lung transplant recipients: evaluation by dynamic 3He-MRI with lung motion correction. Invest Radiol 2003; 38: 341-348.
97. Salerno M, de Lange EE, Altes TA, Truwit JD, Brookeman JR, Mugler JP 3rd,. Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes-initial experience. Radiology 2002; 222: 252-260.
98. Ley S, Zaporozhan J, Morbach A, et al. Functional evaluation of emphysema using diffusion-weighted 3Helium-magnetic resonance imaging, high-resolution computed tomography, and lung function tests. Invest Radiol 2004; 39: 427-434.
99. Conradi MS, Yablonskiy DA, Woods JC, et al. 3He diffusion MRI of the lung. Acad Radiol 2005; 12: 1406-1413.
100. Swift AJ, Wild JM, Fichele S, et al. Emphysematous changes and normal variation in smokers and COPD patients using diffusion 3He MRI. Eur J Radiol 2005; 54: 352-358.
101. Fain SB, Panth SR, Evans MD, et al. Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. Radiology 2006; 239: 875-883.
102. Morbach AE, Gast KK, Schmiedeskamp J, et al. Diffusion-weighted MRI of the lung with hyperpolarized helium-3: a study of reproducibility. J Magn Reson Imaging 2005; 21: 765-774.